Arkolith/Insider Trading/GMED/Form 4

Scavilla Daniel T

President, CEO, DirectorGLOBUS MEDICAL INC (GMED) · full profile →Form 4 · filed Nov 8, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.8M
Net Open-Market Flow
-$4.8M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 6, 2024Sell(S)60K$80.02$4.8M0
Nov 6, 2024Option exercise(M)30K$43.77$1.3M60K
Nov 6, 2024Option exercise(M)30K$26.27$788K30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 6, 2024Option exercise(M)30K—$050K
Nov 6, 2024Option exercise(M)30K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-124113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML